Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations
- PMID: 16079129
- DOI: 10.1074/jbc.M505143200
Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations
Abstract
Mutations in the PTEN-induced kinase 1 (PINK1) gene have recently been implicated in autosomal recessive early onset Parkinson Disease (1, 2). To investigate the role of PINK1 in neurodegeneration, we designed human and murine neuronal cell lines expressing either wild-type PINK1 or PINK1 bearing a mutation associated with Parkinson Disease. We show that under basal and staurosporine-induced conditions, the number of terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL)-positive cells was lower in wild-type PINK1 expressing SH-SY5Y cells than in mock-transfected cells. This phenotype was due to a PINK1-mediated reduction in cytochrome c release from mitochondria, which prevents subsequent caspase-3 activation. We show that overexpression of wild-type PINK1 strongly reduced both basal and staurosporine-induced caspase 3 activity. Overexpression of wild-type PINK1 also reduced the levels of cleaved caspase-9, caspase-3, caspase-7, and activated poly(ADP-ribose) polymerase under both basal and staurosporine-induced conditions. In contrast, Parkinson disease-related mutations and a kinase-inactive mutation in PINK1 abrogated the protective effect of PINK1. Together, these results suggest that PINK1 reduces the basal neuronal pro-apoptotic activity and protects neurons from staurosporine-induced apoptosis. Loss of this protective function may therefore underlie the degeneration of nigral dopaminergic neurons in patients with PINK1 mutations.
Similar articles
-
PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.Neurobiol Dis. 2007 Nov;28(2):216-26. doi: 10.1016/j.nbd.2007.07.010. Epub 2007 Jul 17. Neurobiol Dis. 2007. PMID: 17707122
-
Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress.Neuroscience. 2010 Mar 17;166(2):422-34. doi: 10.1016/j.neuroscience.2009.12.068. Epub 2010 Jan 4. Neuroscience. 2010. PMID: 20045449
-
Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons.Free Radic Biol Med. 2014 Mar;68:220-33. doi: 10.1016/j.freeradbiomed.2013.12.015. Epub 2013 Dec 25. Free Radic Biol Med. 2014. PMID: 24374372
-
Parkin blushed by PINK1.Neuron. 2006 May 18;50(4):527-9. doi: 10.1016/j.neuron.2006.05.003. Neuron. 2006. PMID: 16701203 Review.
-
[Molecular genetics of PINK1].Brain Nerve. 2007 Aug;59(8):831-8. Brain Nerve. 2007. PMID: 17713119 Review. Japanese.
Cited by
-
PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation.J Neuroinflammation. 2012 Dec 17;9:271. doi: 10.1186/1742-2094-9-271. J Neuroinflammation. 2012. PMID: 23244239 Free PMC article.
-
Mitochondrial control of cell bioenergetics in Parkinson's disease.Free Radic Biol Med. 2016 Nov;100:123-137. doi: 10.1016/j.freeradbiomed.2016.04.012. Epub 2016 Apr 16. Free Radic Biol Med. 2016. PMID: 27091692 Free PMC article. Review.
-
Parkinson's disease: what the model systems have taught us so far.J Genet. 2018 Jul;97(3):729-751. J Genet. 2018. PMID: 30027906 Review.
-
Quantitative phosphoproteomic profiling of PINK1-deficient cells identifies phosphorylation changes in nuclear proteins.Mol Biosyst. 2014 Jul;10(7):1719-29. doi: 10.1039/c3mb70565j. Epub 2014 Mar 13. Mol Biosyst. 2014. PMID: 24626860 Free PMC article.
-
PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage.J Med Chem. 2023 Jun 8;66(11):7645-7656. doi: 10.1021/acs.jmedchem.3c00555. Epub 2023 May 29. J Med Chem. 2023. PMID: 37248632 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials